P. Genderen

发表

31 Antihelminthic drugs

P. V. Genderen, P. Genderen, 2007 .

Chapter 31 - Antihelminthic drugs

P. Genderen, 2009 .

Is paromomycin the drug of choice for eradication of Blastocystis in adults?

J. Hellemond, R. Koelewijn, N. Molhoek, 2013, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Scientific Report of the Registry on Acquired von Willebrand Syndrome : Recommendations for Diagnosis and Management

H. Mohri, P. Bucciarelli, J. Rand, 2000 .

3 Acquired von Willebrand disease

J. Michiels, P. V. Genderen, P. Genderen, 1998 .

Acquired von Willebrand disease as a cause of recurrent mucocutaneous bleeding in primary thrombocythemia: Relationship with platelet count

J. Michiels, P. V. Genderen, H. Vliet, 1994, Annals of Hematology.

Acquired von Willebrand's disease. Evidence for a quantitative and qualitative factor VIII disorder.

J. Michiels, P. V. Genderen, P. Genderen, 1978 .

Primary thrombocythemia: diagnosis, clinical manifestations and management

J. Michiels, P. V. Genderen, P. Genderen, 1993, Annals of Hematology.

Polycythaemia Vera and Essential Thrombocythaemia in the Elderly

P. V. Genderen, M. M. Troost, P. Genderen, 2000, Drugs & aging.

Platelet Consumption in Thrombocythemia Complicated by Erythromelalgia: Reversal by Aspirin

P. V. van Genderen, J. Lindemans, R. van Strik, 1995, Thrombosis and Haemostasis.

From the Clinic

N. Goemaere, A. Alphen, P. Genderen, 2012 .

From the Clinic Collapsing glomerulopathy after Plasmodium falciparum infection

N. Goemaere, A. Alphen, P. Genderen, 2014 .

Analysis of mechanisms involved in reduced susceptibility to ciprofloxacin in serotypes Typhi and Paratyphi A isolates from travellers to Southeast Asia

G. Menezes, W. Goessens, R. Hassing, 2018 .

CLASSIFICATION AND DIAGNOSIS OF ERYTHROMELALGIA AND ERYTHERMALGIA

J. Drenth, J. Michiels, P. V. Genderen, 1995, International journal of dermatology.

Effectiveness of High‐Dose Intravenous Gamma Globulin Therapy in Acquired von Willebrand's Disease

J. Michiels, J. Bakker, M. Veer, 1994, Vox sanguinis.

Aspirin responsive platelet thrombophilia in essential thrombocythemia and polycythemia vera

P. Koudstaal, J. Michiels, F. Kate, 2013 .

an analysis of EuroTravNet longitudinal, surveillance data, and evaluation of the eff ect of the pre-travel consultation

R. López-Vélez, N. Beeching, R. Weber, 2014 .

Excessive prolongation of the Ivy bleeding time after aspirin in essential thrombocythemia is also demonstrable in vitro in the high shear stress system PFA-100

M. M. Troost, P. Genderen, 2002, Annals of Hematology.

Pathophysiological aspects of Platelet-Mediated Thrombosis and Bleeding in Essential Thrombocythemia:

P. Genderen, 1998 .

Researchin imported malaria is common and associated with disease severity

R. Zietse, E. Hoorn, D. Hesselink, 2010 .

Erythromelalgic, thrombotic and haemorrhagic manifestations of thrombocythaemia.

P. V. van Genderen, J. Michiels, P. Genderen, 1994, Presse medicale.

Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis.

A. Green, M. Griesshammer, P. V. van Genderen, 1999 .

Erythromelalgic, thrombotic and hemorrhagic manifestations in 50 cases of thrombocythemia.

P. V. van Genderen, J. Lindemans, J. Michiels, 1996, Leukemia & lymphoma.

Cross-reactivity of antibodies to viruses belonging to the Semliki forest serocomplex.

P. V. van Genderen, I. Leparc-Goffart, R. Hassing, 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Excessive prolongation of the bleeding time by aspirin in essential thrombocythemia is related to a decrease of large von Willebrand factor multimers in plasma

P. V. van Genderen, R. van Strik, U. Budde, 1997, Annals of Hematology.

HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY von Willebrand Factor Propeptide in Vascular Disorders: A Tool to Distinguish Between Acute and Chronic Endothelial Cell Perturbation

P. V. van Genderen, J. V. van Mourik, D. Pajkrt, 1999 .

Coagulation disorders in young adults with acute cerebral ischaemia

P. V. van Genderen, P. Koudstaal, D. Dippel, 1997, Journal of Neurology.

Acute muscular sarcocystosis: an international investigation among ill travelers returning from Tioman Island, Malaysia, 2011-2012.

P. V. van Genderen, C. Goldsmith, M. Sotir, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Atypical transient ischemic attacks in thrombocythemia of various myeloproliferative disorders.

P. V. van Genderen, P. Koudstaal, J. Michiels, 1996, Leukemia & lymphoma.

Hypereosinophilia: a diagnostic challenge.

P. V. van Genderen, H. Kluin-Nelemans, J. Hellemond, 2018, The Netherlands journal of medicine.

Acquired von Willebrand disease caused by an autoantibody selectively inhibiting the binding of von Willebrand factor to collagen.

P. V. van Genderen, J. Sixma, T. Vink, 1994, Blood.

Lipoxygenase Deficiency in Primary Thrombocythemia Is not a True Deficiency

F. Zijlstra, J. Michiels, P. Genderen, 1994, Thrombosis and Haemostasis.

HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY von Willebrand Factor Propeptide in Vascular Disorders: A Tool to Distinguish Between Acute and Chronic Endothelial Cell Perturbation

D. Pajkrt, K. Fijnvandraat, R. Fijnheer, 1999 .

Acquired von Willebrand disease in myeloproliferative disorders.

P. V. van Genderen, U. Budde, J. Michiels, 1996, Leukemia & lymphoma.

High-dose intravenous gammaglobulin therapy for acquired von Willebrand disease.

P. V. van Genderen, D. Papatsonis, F. Huikeshoven, 1994, Postgraduate medical journal.